Last update 24 Aug 2026

BMS-986528

Overview

Basic Info

Drug Type
T cell engagers (TCE)
Synonyms
BMS-986528
Target
CD19 x CD3
Action
modulators, stimulants
Mechanism
CD19 modulators(B-lymphocyte antigen CD19 modulators), CD3 stimulants(T cell surface glycoprotein CD3 stimulants)
Therapeutic Areas
Immune System DiseasesSkin and Musculoskeletal Diseases
Active Indication
Rheumatoid Arthritis
Inactive Indication-
Originator Organization
Bristol Myers Squibb Co.Bristol Myers Squibb Co.
Active Organization
Bristol Myers Squibb Co.Bristol Myers Squibb Co.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with BMS-986528
NCT07412704
/ RecruitingPhase 1/2
A Phase 1/2a, Open-label, First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of BMS-986528 in Participants With Refractory Rheumatoid Arthritis
100 Clinical Results associated with BMS-986528
Login to view more data
100 Translational Medicine associated with BMS-986528
Login to view more data
100 Patents (Medical) associated with BMS-986528
Login to view more data
100 Deals associated with BMS-986528
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Rheumatoid ArthritisPhase 2
United States
Bristol Myers Squibb Co.Bristol Myers Squibb Co.
15 Sep 2026
Rheumatoid ArthritisPhase 2
China
Bristol Myers Squibb Co.Bristol Myers Squibb Co.
15 Sep 2026
Rheumatoid ArthritisPhase 2
Belgium
Bristol Myers Squibb Co.Bristol Myers Squibb Co.
15 Sep 2026
Rheumatoid ArthritisPhase 2
Brazil
Bristol Myers Squibb Co.Bristol Myers Squibb Co.
15 Sep 2026
Rheumatoid ArthritisPhase 2
Germany
Bristol Myers Squibb Co.Bristol Myers Squibb Co.
15 Sep 2026
Rheumatoid ArthritisPhase 2
Italy
Bristol Myers Squibb Co.Bristol Myers Squibb Co.
15 Sep 2026
Rheumatoid ArthritisPhase 2
Mexico
Bristol Myers Squibb Co.Bristol Myers Squibb Co.
15 Sep 2026
Rheumatoid ArthritisPhase 2
Poland
Bristol Myers Squibb Co.Bristol Myers Squibb Co.
15 Sep 2026
Rheumatoid ArthritisPhase 2
Spain
Bristol Myers Squibb Co.Bristol Myers Squibb Co.
15 Sep 2026
Rheumatoid ArthritisPhase 2
Switzerland
Bristol Myers Squibb Co.Bristol Myers Squibb Co.
15 Sep 2026
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free